Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

     1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Type

  2.3.2 Market Size By End Use

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

3.4.1. Raw Material & Coating Technology Suppliers
3.4.2. DCB Catheter Manufacturers & Assemblers
3.4.3. Distributors & Interventional Supply Partners
3.4.4. Hospitals, Cardiac Centers & End Users

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Clinical Efficacy & Performance Metrics

  4.1.1 Average Reduction in Target Lesion Revascularization (TLR) Rates with DCB Use (%)

  4.1.2 Average Late Lumen Loss (LLL) Observed Post-DCB Treatment (mm)

  4.1.3 Percentage Improvement in Primary Patency Rates at 12 Months (%)

  4.1.4 Average Drug Transfer Efficiency of Coating Technologies During Balloon Inflation (%)

  4.1.5 Percentage Reduction in Restenosis Rates Compared to Plain Balloon Angioplasty (%)

 4.2 Procedure Adoption & Utilization Statistics

  4.2.1 Annual Growth in DCB Angioplasty Procedure Volume (%)

  4.2.2 Share of DCB Procedures in Total Percutaneous Coronary Interventions (%)

  4.2.3 Share of DCB Procedures in Total Peripheral Interventions (%)

  4.2.4 Percentage of Interventional Cardiologists Preferring DCB Over Drug-Eluting Stents in Select Lesions (%)

  4.2.5 Average Number of DCB Catheters Used per Procedure (Units)

 4.3 Technology & Product Development Metrics

  4.3.1 Share of Paclitaxel-Coated vs. Sirolimus-Coated DCB Products (%)

  4.3.2 Percentage of DCBs Featuring Novel Coating Technologies (e.g., Microcrystalline, Polymer-Free) (%)

  4.3.3 Average Drug Dosage per DCB Unit (µg/mm²)

  4.3.4 Percentage of DCB Products with CE Mark or FDA Approval (%)

  4.3.5 Share of Next-Generation DCBs with Improved Trackability & Crossability (%)

 4.4 Safety & Patient Outcome Indicators

  4.4.1 Average Reduction in Major Adverse Cardiac Events (MACE) with DCB Use (%)

  4.4.2 Percentage Reduction in Vessel Perforation or Dissection Rates with DCB (%)

  4.4.3 Average Improvement in Patient Quality of Life Scores Post-DCB Procedure (%)

  4.4.4 Percentage Reduction in Dual Antiplatelet Therapy (DAPT) Duration with DCB vs. Stents (%)

  4.4.5 Average Cost Savings per Procedure Using DCB Compared to Stent-Based Interventions (USD)

5. Drug-Coated Balloon Catheters Market Segmental Analysis & Forecast, By Type, 2022–2035, Value (USD Billion)

 5.1 Introduction
 5.2 Coronary DCB
  5.2.1 Key Trends
  5.2.2 Market Size & Forecast, 2022 – 2035
 5.3 Peripheral DCB

6. Drug-Coated Balloon Catheters Market Segmental Analysis & Forecast, By End Use, 2022–2035, Value (USD Billion)

 6.1 Introduction
 6.2 Hospitals
  6.2.1 Key Trends
  6.2.2 Market Size & Forecast, 2022–2035
 6.3 Specialty Cardiac/Vascular Centers
 6.4 Ambulatory Surgical Centers (ASCs)

7. Drug-Coated Balloon Catheters Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

 7.1 Introduction

 7.2 North America

  7.2.1 Key Trends

  7.2.2 Drug-Coated Balloon Catheters Market Size & Forecast, By Type, 2022–2035

  7.2.3 Drug-Coated Balloon Catheters Market Size & Forecast, By End Use, 2022–2035

  7.2.4 Drug-Coated Balloon Catheters Market Size & Forecast, By Country, 2022–2035

   7.2.4.1 USA

   7.2.4.2 Canada

7.3 Europe

 7.3.1 Key Trends

 7.3.2 Drug-Coated Balloon Catheters Market Size & Forecast, By Type, 2022–2035

 7.3.3 Drug-Coated Balloon Catheters Market Size & Forecast, By End Use, 2022–2035

 7.3.4 Drug-Coated Balloon Catheters Market Size & Forecast, By Country, 2022–2035

  7.3.4.1 Germany

  7.3.4.2 UK

  7.3.4.3 France

  7.3.4.4 Italy

  7.3.4.5 Spain

  7.3.4.6 Russia

  7.3.4.7 Poland

  7.3.4.8 Rest of Europe

7.4 Asia-Pacific

 7.4.1 Key Trends

 7.4.2 Drug-Coated Balloon Catheters Market Size & Forecast, By Type, 2022–2035

 7.4.3 Drug-Coated Balloon Catheters Market Size & Forecast, By End Use, 2022–2035

 7.4.4 Drug-Coated Balloon Catheters Market Size & Forecast, By Country, 2022–2035

  7.4.4.1 China

  7.4.4.2 India

  7.4.4.3 Japan

  7.4.4.4 South Korea

  7.4.4.5 Australia

  7.4.4.6 ASEAN Countries

  7.4.4.7 Rest of Asia-Pacific

7.5 Latin America

 7.5.1 Key Trends

 7.5.2 Drug-Coated Balloon Catheters Market Size & Forecast, By Type, 2022–2035

 7.5.3 Drug-Coated Balloon Catheters Market Size & Forecast, By End Use, 2022–2035

 7.5.4 Drug-Coated Balloon Catheters Market Size & Forecast, By Country, 2022–2035

  7.5.4.1 Brazil

  7.5.4.2 Argentina

  7.5.4.3 Mexico

  7.5.4.4 Colombia

  7.5.4.5 Rest of Latin America

7.6 Middle East & Africa

 7.6.1 Key Trends

 7.6.2 Drug-Coated Balloon Catheters Market Size & Forecast, By Type, 2022–2035

 7.6.3 Drug-Coated Balloon Catheters Market Size & Forecast, By End Use, 2022–2035

 7.6.4 Drug-Coated Balloon Catheters Market Size & Forecast, By Country, 2022–2035

  7.6.4.1 UAE

  7.6.4.2 Saudi Arabia

  7.6.4.3 Qatar

  7.6.4.4 South Africa

  7.6.4.5 Rest of Middle East & Africa

8. Competitive Landscape

 8.1 Key Players' Positioning

 8.2 Competitive Developments

  8.2.1 Year-Wise Strategies & Development, 2022–2026

 8.3 Market Share Analysis, 2025

 8.4 Product/Service & Application Benchmarking

  8.4.1 Product/Service Specifications & Features By Key Players

  8.4.2 Product/Service Heatmap By Key Players

  8.4.3 Application Heatmap By Key Players

 8.5 Industry Start-Up & Innovation Landscape

8.6 Key Company Profiles

  8.6.1 Boston Scientific Corporation

8.6.1.1 Company Overview & Snapshot

8.6.1.2 Product/Service Portfolio

8.6.1.3 Key Company Financials

8.6.1.4 Geographical Presence

8.6.1.5 SWOT Analysis

8.6.2 Medtronic plc
8.6.3 B. Braun SE
8.6.4 Concept Medical Inc.
8.6.5 Abbott
8.6.6 Koninklijke Philips N.V.
8.6.7 Teleflex Incorporated (BIOTRONIK)
8.6.8 Translumina
8.6.9 MicroPort Scientific Corporation
8.6.10 Cardionovum GmbH
8.6.11 iVascular S.L.U.
8.6.12 Lepu Medical Technology
8.6.13 Meril Life Sciences Pvt. Ltd.
8.6.14 Cordis
8.6.15 Acotec Scientific Holdings
8.6.16 SMT (Sahajanand Medical Technologies)
8.6.17 Bayer AG
8.6.18 BrosMed Medical

9. Analyst Recommendations

 9.1 SNS Insider Opportunity Map

 9.2 Industry Low-Hanging Fruit Assessment

 9.3 Market Entry & Growth Strategy

 9.4 Analyst Viewpoint & Suggestions On Market Growth

10. Assumptions

11. Disclaimer

12. Appendix

 12.1 List Of Tables

 12.2 List Of Figures